Should the FDA Regulate Peptides Like Prescription Drugs?

The debate over peptide regulation has intensified following a controversial vote by an FDA advisory panel. With peptides trending in beauty and wellness industries, some argue that tighter regulation is necessary to ensure safety, while others believe such measures would stifle innovation and accessibility. This issue touches on public health, consumer freedom, and the balance between innovation and oversight.